Efficacy of different neoadjuvant treatment regimens in BRCA-mutated triple negative breast cancer: a systematic review and meta-analysis

Peer Review reports

Original Submission
25 Apr 2022	Submitted	Original manuscript
24 Jun 2022	Reviewed	Reviewer Report
15 Aug 2022	Reviewed	Reviewer Report - Elena Savonevich
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
17 Aug 2022	Editorially accepted
9 Sep 2022	Article published	10.1186/s13053-022-00242-0

Back to article page